The COVID Advisor

A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way.   Dr. Harvey Risch first reported in September 2023 that Clinicians at Yale Medical School were seeing some new cancer situations in adults as young as 25, with no family history of developing colorectal cancer, suddenly developing highly aggressive forms of the disease. So aggressive that between diagnosis and first treatment, the cancers have grown dramatically (1). This phenomenon has rapidly accelerated since the Pandemic. These ‘turbo cancers’ do not conform to the normal behaviour of cancers, not only are they more aggressive, but there seem to be more genetic issues in these cancers. Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.   In 2022 ther...

Studies and case reports of various cancers following mRNA vaccination are helping experts understand the potential mechanisms that may be allowing these cancers to proliferate.   Case Reports of Turbo Cancer Case 1 Dr William Makis shared on X/Twitter in March 2025: TURBO CANCER - 34 year old Katie Thurston, a star of "The Bachelorette" was diagnosed with Stage 3 Breast Cancer.  She had COVID-19 Vaccines in 2021 and promoted them. Pfizer and Moderna COVID-19 mRNA Vaccines cause Turbo Cancer and Breast cancer is the 2nd most common Turbo Cancer.  Millions of mRNA Vaccinated women face an elevated breast cancer risk as a result of the jabs, for the rest of their lives.  Stage 3 Breast cancer in a 34 year old woman? This used to be rare. Sadly, not anymore! TURBO CANCER - 34 year old Katie Thurston, a star of "The Bachelorette" was diagnosed with Stage 3 Breast Cancer She had COVID-19 Vaccines in 2021 and promoted them. Pfizer and...

The FLCCC (Front Line COVID-19 Critical Care Alliance) was formed by leading critical care specialists in March 2020, at the beginning of the Coronavirus pandemic, dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease. Though there are many long haulers treatment protocols out there, we consider and recommend the I-Recover protocol as one of the best. This protocol has also been used to treat post-vaccine inflammatory syndromes with similar success. As with all FLCCC Alliance protocols, the components, doses, and durations will evolve as more clinical data accumulates.  The I-Recover protocol (Long COVID) has been updated and below is their latest version ( March 2024 ).  Treatment must be individualized according to each patient’s presenting symptoms and disease syndromes. It is likely that not all patients will respond equally to the same intervention; a particul...